Document Detail

Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC).
MedLine Citation:
PMID:  24474086     Owner:  NLM     Status:  Publisher    
Collectin kidney 1 (CL-K1) is a recently identified collectin that is synthesized in most organs and circulates in blood. CL-K1 is an innate immune molecule that may play a significant role in host defense. As some collectins also play a role in coagulation, we hypothesized that an effect of CL-K1 may be apparent in disseminated intravascular coagulation (DIC), a gross derangement of the coagulation system that occurs in the setting of profound activation of the innate immune system. DIC is a grave medical condition with a high incidence of multiple organ failure and high mortality and yet there are no reliable biomarkers or risk factors. In our present study, we measured plasma CL-K1 concentration in a total of 659 specimens, including 549 DIC patients, 82 non-DIC patients and 27 healthy volunteers. The median plasma CL-K1 levels in these cohorts were 424, 238 and 245 ng/ml, respectively, with no significant difference in the latter two groups. The incidence of elevated plasma CL-K1 was significantly higher in the DIC patients compared to the non-DIC patients, resulting in an odds ratio of 1.929 (confidence interval 1.041-3.866). Infection, renal diseases, respiratory diseases, and cardiac diseases were more frequently observed in the DIC group than in the non-DIC group. In the DIC group, vascular diseases were associated with elevated plasma CL-K1 levels while age and acute illness had little effect on plasma CL-K1 levels. Independent of DIC, elevated plasma CL-K1 levels were associated with respiratory disease and coagulation disorders. These results suggest that specific diseases may affect CL-K1 synthesis in an organ dependent manner and that elevated plasma CL-K1 levels are associated with the presence of DIC. Further investigations in cohorts of patients are warranted. We propose that elevated plasma CL-K1 may be a new useful risk factor and possibly biomarker for the prediction of developing DIC.
Kazue Takahashi; Katsuki Ohtani; Mykol Larvie; Patience Moyo; Lorencia Chigweshe; Elizabeth M Van Cott; Nobutaka Wakamiya
Related Documents :
23406896 - Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal an...
23864056 - Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin ...
23223086 - Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia.
23605146 - Ochratoxin a in human blood serum - retrospective long-term data.
3885156 - Effects of hydrochlorothiazide and amiloride in renal hypophosphatemic rickets.
6422976 - Effect of bromocriptine on menstrual cycle length.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-1-29
Journal Detail:
Title:  Journal of thrombosis and thrombolysis     Volume:  -     ISSN:  1573-742X     ISO Abbreviation:  J. Thromb. Thrombolysis     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-1-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9502018     Medline TA:  J Thromb Thrombolysis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery fo...
Next Document:  Beneficial effects of hydro-alcoholic extract of Caralluma fimbriata against high-fat diet-induced i...